Nanoscale metal–organic framework-mediated immunogenic cell death boosting tumor immunotherapy
Immunotherapy has evolved into a powerful therapeutic strategy for tumor prevention and treatment. Immunogenic cell death (ICD) causes the release of danger-associated molecular patterns (DAMPs), which trigger adaptive immune cells to elicit an antitumor immune response. The ICD induced by nanoscale...
Main Authors: | Weidong Ni, Wenhao Zhu, Wen Wu, Jie Chen, Ping Ren, Fangfang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Materials & Design |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0264127522006906 |
Similar Items
-
Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
by: Xiaotian He, et al.
Published: (2023-06-01) -
Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Ken Maes, et al.
Published: (2019-07-01) -
Pan‐cancer analyses of immunogenic cell death‐derived gene signatures: Potential biomarkers for prognosis and immunotherapy
by: Xiaodan Han, et al.
Published: (2024-04-01) -
A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
by: Bingqi Dong, et al.
Published: (2023-05-01) -
Nanomedicine based on chemotherapy-induced immunogenic death combined with immunotherapy to enhance antitumor immunity
by: Yichang Chen, et al.
Published: (2024-12-01)